Argireline (Acetyl Hexapeptide-3) and Neuronal Synapses

Acetyl Hexapeptide-3 (commonly termed as Argireline or acetyl hexapeptide-8 amide) is a synthetic peptide composed of six amino acids arranged in the sequence of Ac-EEMQRR-NH2 (N-acetyl – L-alpha-glutamyl – L-alpha-glutamyl – L-methionyl – L-glutaminyl – L-arginyl – L-arginine amide). The acetylation of the peptide is posited to support its potential to permeate through different tissues, such as dermal tissue, in laboratory settings. It has gained attention for its potential molecular mechanisms that may influence the release of neurotransmitters at neuromuscular synapses. Consequently, it is often studied in research related to experimental models of skin structure topography, scarring, muscular tissue spasms, and others. Modified versions of the peptide are also studied in the context of nociception.

Figure 1: Acetyl Hexapeptide-3 chemical structure

 

Research

Argireline (Acetyl Hexapeptide-3) and The SNARE Complex

Acetyl Hexapeptide-3 may engage with molecular pathways tied to neurotransmitter discharge, perhaps by interacting with proteins that may be critical for synaptic function. Blanes-Mira et al. have suggested that the observed inhibition of  neurotransmitter release may be “due to the interference of the hexapeptide with the formation and/or stability of the protein complex that is required to drive Ca(2+)-dependent exocytosis, namely the vesicular fusion (known as SNARE) complex.“^[1] Specifically, structural similarities between the peptide and this complex may allow the former to act as a competitive inhibitor of specific molecular elements, including SNAP25, a component possibly related to a family of proteins often called SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors).

These SNARE proteins are thought to form a complex that is believed to potentially facilitate the fusion of neurotransmitter-containing vesicles with the synaptic membrane. In particular, SNAP25 is sometimes viewed as a key element that might assist in positioning and stabilizing the fusion machinery. This entire assembly, which may guide Ca[2+]-dependent exocytosis of neurotransmitters like acetylcholine, may prove essential for synaptic signal transmission. Khvotchev et al. have posited that if acetylcholine release is dampened, such changes might lower communication at neuromuscular junctions and potentially diminish muscle cell contraction.^[2]

Argireline (Acetyl Hexapeptide-3) and Collagen Synthesis

In research conducted by Wang et al. using murine models, Argirelin apparently interacted with the dermal extracellular matrix in ways that may influence collagen production and organization.^[3] Through mechanisms that are not fully elucidated, it potentially altered the balance between different types of collagen fibers. In particular, it was posited to facilitate a relative increase in type I collagen fibers while apparently decreasing type III collagen fibers within the dermal tissue. This shift in collagen composition, possibly mediated by changes in fibroblast activity or downstream signaling pathways related to collagen synthesis, might underscore Argirelin’s potential capacity to help maintain or restore a more ordered and mature collagen fiber network.

Type III collagen fibers are often associated with the formation of scar tissue. Due to its potential for reducing type III collagen fibers, Acetyl Hexapeptide-3 may also help reduce scarring in research models of tissue regeneration. Palmieri et al. commented that the peptide appears to increase the elasticity of scarred tissue “from 33,5% to 40,5% (…) in left lateral-medial area of the neck and malar area; from 24% to 31,5% (…) in right lateral- medial area of the neck and malar area; and from 25,5% to 38% (…) in forehead and chin area.“^[4]

Argireline (Acetyl Hexapeptide-3) and Dermal Layer Wrinkles

Multiple investigations appear to indicate that Acetyl Hexapeptide-3 may help decrease the depth of wrinkles under laboratory conditions, though the extent of any visible supports remains difficult to confirm. According to Blanes-Mira et al., the degree of observed reductions in wrinkle severity appears to be within the 30-50% range.^[1] For example, Wang et al. conducted a notable experiment. The researchers commented that “the total anti-wrinkle efficiency in the treatment group was 48.9%, and the depth of the wrinkles was notably reduced.“^[5] Some research has also proposed that this peptide might reduce transepidermal water loss (TEWL), a factor potentially influencing dermal layer hydration.

Although any related supports in appearance remain speculative, Raikou et al. also suggested the possibility that better-supported moisture retention might be involved, which is not a possibility that is easy to dismiss.^[6] The underlying mechanisms responsible for these observations continue to be investigated, and additional data may potentially clarify the degree to which Acetyl Hexapeptide-3 offers reliable, reproducible, relevant data points.

Argireline (Acetyl Hexapeptide-3) and Muscular Tissue Spasms

In controlled laboratory investigations, Lungu et al. have suggested that Acetyl Hexapeptide-3 may indicate a potential to reduce muscular tissue spasms in a manner that resembles bacterial toxins. For context, bacterial toxins are the staple tool for researching muscular tissue spasm mitigation in lab settings, and they are believed to inhibit acetylcholine release.^[7] However, while bacterial toxins apparently achieve prolonged suppression of neuromuscular activity by cleaving SNAP-25, Acetyl Hexapeptide-3 seems to rely on competitive interference rather than permanent proteolytic action. This difference may result in a shorter duration of action, with muscular tissue spasms potentially returning more quickly than when bacterial toxins are employed. This is something that should be considered by researchers comparing different research tools.

The potential of Modified Argireline (Acetyl Hexapeptide-3)

Ponsati has suggested that Acetyl Hexapeptide-3 may be modified with fatty acids to potentially support its permeation through dermal layers and extend its research potential. For example, palmitoylated acetyl hexapeptide-3, when studied in a laboratory setting and possibly in murine models, is said to potentially interfere with mechanisms underlying the exocytosis of key proteins in nociceptive neurons.^[8] It may reduce the vesicular fusion events that deliver transient receptor potential vanilloid 1 (TRPV1) channels and certain neuropeptides, such as calcitonin gene-related peptide (CGRP), to the neuronal surface.

This blockage of Ca²⁺-dependent membrane trafficking may be posited to dampen the overall sensitization of nociceptive fibers. By limiting the exocytotic recruitment of TRPV1 channels, the peptide might mitigate their inflammatory upregulation. The consequent suppression of proinflammatory peptide release and the potential dampening of TRPV1 channel density on the nociceptor surface may, in theory, reduce the neuron’s responsiveness to noxious stimuli.

 
NOTE: These products are intended for laboratory research use only. This peptide is not intended for personal use. Please review and adhere to our Terms and Conditions before ordering.

 

References:

1. Blanes-Mira C, Clemente J, Jodas G, Gil A, Fernández-Ballester G, Ponsati B, Gutierrez L, Pérez-Payá E, Ferrer-Montiel A. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002 Oct;24(5):303-10. doi: 10.1046/j.1467-2494.2002.00153.x. PMID: 18498523.
2. Khvotchev M, Soloviev M. SNARE Modulators and SNARE Mimetic Peptides. Biomolecules. 2022 Nov 29;12(12):1779. doi: 10.3390/biom12121779. PMID: 36551207; PMCID: PMC9776023.
3. Wang Y, Wang M, Xiao XS, Huo J, Zhang WD. The anti-wrinkle efficacy of Argireline. J Cosmet Laser Ther. 2013 Aug;15(4):237-41. doi: 10.3109/14764172.2013.769273. Epub 2013 Mar 6. PMID: 23464592.
4. Palmieri B, Noviello A, Corazzari V, Garelli A, Vadala M. Skin scars and wrinkles temporary camouflage in dermatology and anesthetics: focus on acetyl hexapeptide-8. Clin Ter. 2020 Nov-Dec;171(6):e539-e548. doi: 10.7417/CT.2020.2270. PMID: 33151254.
5. Wang Y, Wang M, Xiao XS, Pan P, Li P, Huo J. The anti-wrinkle efficacy of synthetic hexapeptide (Argireline) in Chinese Subjects. J Cosmet Laser Ther. 2013 Apr 22. doi: 10.3109/14764172.2012.759234. Epub ahead of print. PMID: 23607739.
6. Raikou V, Varvaresou A, Panderi I, Papageorgiou E. The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3. A prospective, randomized controlled study. J Cosmet Dermatol. 2017 Jun;16(2):271-278. doi: 10.1111/jocd.12314. Epub 2017 Feb 2. PMID: 28150423.
7. Lungu C, Considine E, Zahir S, Ponsati B, Arrastia S, Hallett M. Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy. Eur J Neurol. 2013 Mar;20(3):515-518. doi: 10.1111/ene.12009. Epub 2012 Nov 12. PMID: 23146065; PMCID: PMC4747634.
8. Ponsati B, Carreño C, Curto-Reyes V, Valenzuela B, Duart MJ, Van den Nest W, Cauli O, Beltran B, Fernandez J, Borsini F, Caprioli A, Di Serio S, Veretchy M, Baamonde A, Menendez L, Barros F, de la Pena P, Borges R, Felipo V, Planells-Cases R, Ferrer-Montiel A. An inhibitor of neuronal exocytosis (DD04107) displays long-lasting in vivo activity against chronic inflammatory and neuropathic pain. J Pharmacol Exp Ther. 2012 Jun;341(3):634-45. doi: 10.1124/jpet.111.190678. Epub 2012 Mar 5. PMID: 22393248.